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Following the discovery of the vasorelaxant properties of nitric oxide (NO) by Furchgott and
Ignarro, the finding by Bredt and coll. of a constitutively expressed NO synthase in neurons
(nNOS) led to the presumption that neuronal NO may control cerebrovascular functions.
Consequently, numerous studies have sought to determine whether neuraly-derived NO
is involved in the regulation of cerebral blood flow (CBF). Anatomically, axons, dendrites,
or somata of NO neurons have been found to contact the basement membrane of
blood vessels or perivascular astrocytes in all segments of the cortical microcirculation.
Functionally, various experimental approaches support a role of neuronal NO in the
maintenance of resting CBF as well as in the vascular response to neuronal activity.
Since decades, it has been assumed that neuronal NO simply diffuses to the local
blood vessels and produce vasodilation through a cGMP-PKG dependent mechanism.
However, NO is not the sole mediator of vasodilation in the cerebral microcirculation and
is known to interact with a myriad of signaling pathways also involved in vascular control.
In addition, cerebrovascular regulation is the result of a complex orchestration between all
components of the neurovascular unit (i.e., neuronal, glial, and vascular cells) also known
to produce NO. In this review article, the role of NO interneuron in the regulation of cortical
microcirculation will be discussed in the context of the neurovascular unit.
Keywords: astrocyte, autoregulation, cerebral blood flow, GABA, interneuron, magnetic resonance imaging,
neurovascular coupling, nitric oxide
INTRODUCTION
Nitric oxide (NO) is a small inorganic, labile gaseous molecule
originally identified as endothelium-derived relaxing factor
(EDRF) mediating relaxation of blood vessels (Furchgott and
Zawadzki, 1980). NO is produced through the enzymatic con-
version of L-arginine to L-citrulline by the enzyme NO syn-
thase (NOS). NOS includes three main isoforms: the constitutive
endothelial eNOS and neuronal nNOS as well as the inducible
iNOS. The discovery by Bredt and colleagues (Bredt and Snyder,
1989) that NO is also produced in the brain led to the finding that
NO could act as a neurotransmitter and a modulator of cerebral
blood flow (CBF).
CBF is regulated by two main mechanisms: autoregulation
and neurovascular coupling (NVC). CBF autoregulation is the
primary mechanism ensuring that the flow and supply of oxy-
gen, glucose, and nutrients through the vascular beds remain
within the upper and lower limits of the autoregulatory range
(50–160mm Hg) during fluctuations in systemic arterial pres-
sure. NVC is the dynamic link between neuronal energy needs
and hemodynamic changes. In the cortex, NVC depends on the
complex interplay between neurons, astrocytes, and microves-
sels (endothelial cells, myocytes, and pericytes) that form the
“neurovascular unit” (Iadecola, 2004). NO is known to play a
pivotal role in mechanisms underlying both autoregulation and
NVC. However, although many studies have attempted to eluci-
date the role of NO in the CBF regulation, the exact source of
NO involved at different levels of CBF regulation as well as its
molecular and cellular targets remains unresolved. This review
article will focus on the physiological role of a specific subsets NO
producing gamma aminobutyric acid (GABA)ergic neurons, the
NOS interneurons in control of cortical CBF. The current knowl-
edge on this topic will be critically examined in the context of the
neurovascular unit.
ANATOMICAL RELATIONSHIP BETWEEN NO
INTERNEURONS AND BLOOD VESSELS
The intracortical NOS interneurons are part of a family of GABA
inhibitory interneurons believed to play a pivotal role in CBF
regulation. Indeed, NOS interneurons have been demonstrated
to be ideally positioned between glutamatergic pyramidal cells
and local microvessels (Cauli et al., 2004). Most anatomical
studies on NOS interneurons have used immunohistochemistry
for the nicotinamide adenine dinucleotide phosphate-diaphorase
(NADPHd) which constitutes a histochemical marker for nNOS.
This method is prefered for use due to its simplicity compared
to NOS immunohistochemistry and in situ hybridization since it
requires only two reagents, nitro blue tetrazolium and NADPH.
Histochemistry for NADPHd is believed to be very specific for
nNOS in aldehyde-fixed mammalian brain tissue (Matsumoto
et al., 1993). Firstly, in the neocortex of many species the overlap
of immunocytochemical staining of nNOS and NADPHd is quasi
absolute in neurons. Secondly, in situ hybridization for nNOS
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mRNA in combination with NADPHd show that each positive
cell for NADPHd in rat cerebral cortex also exhibits autoradio-
graphic staining for nNOS mRNA (Bredt et al., 1991). Thirdly,
the deletion of the gene coding for nNOS results in the absence of
NADPHd staining in mice nervous sytem (Huang et al., 1993).
Cortical NADPHd neurons are divided in type I and type
II neurons according to the intensity of staining. Type I cells
exhibit large somata and are intensely stained while type II cells
are much smaller and weakly stained (Kubota et al., 1994; Yan
et al., 1996). Type I neurons are found in the cortex of various
species including mouse, cat, monkey, and humans. Their dis-
tribution pattern is similar between species and are found in all
cortical layers (Sandell, 1986; Mizukawa et al., 1988; Oermann
et al., 1999; Garbossa et al., 2005). The numerical density of type
I cells is lower in the monkey than in the rat (Yan et al., 1994).
Type II cells have a smaller soma and lower NADPHd activity, and
are 20-fold more numerous than type I cells in primates. Type II
cells are found mainly in the supragranular layers in monkey (Yan
et al., 1996) and human (Judas et al., 1999) while, in rodents, they
are about twofold more numerous than type I cells and popu-
late all neocortical layers (Perrenoud et al., 2012b). In primates,
pyramidal cells also present some NADPHd reactivity or nNOS
immunostaining in different cortical areas (Barone and Kennedy,
2000; Garbossa et al., 2005). Although the association of type I
interneurons with blood vessels have been recently described in
the adult monkey (Rockland and Nayyar, 2012) the association of
type II neurons with blood vessels remain to be described.
Around 80% of NADPHd positive cells in the rat cortex
contain GABA and they account for 2% of the GABAergic
cells (Valtschanoff et al., 1993) which represent about 15% of
cortical neurons in rodents (Gabbott et al., 1997). NADPHd-
positive interneurons co-express many vasoactive mediators such
as GABA, neuropeptide Y (NPY), somatostatin (SOM), and cal-
bindin (Kummer et al., 1992; Kubota et al., 1994; Xiao et al., 1996;
Abounader and Hamel, 1997; Gonchar and Burkhalter, 1997;
Estrada and DeFelipe, 1998). Indeed, using patch-clamp record-
ings, biocytin labeling, and single-cell reverse transcriptase-PCR,
Karagiannis et al. (2009), showed that nNOS was expressed by 9%
of fast spiking parvalbumin (PV)-interneurons, 6% of adapting
SOM-interneurons, 2% of adapting vasoactive intestinal peptide
(VIP)-interneurons, 0% of bursting VIP-interneurons, and 26%
of adapting NPY-interneurons. More recently, double labeling
studies showed colocalisation of cytochrome P450 2C11 epoxy-
genase and soluble epoxygenase with nNOS within perivascular
nerves which suggests synthesis of the vasodilator eicosatrienoic
acids in nitrergic nerves (Iliff et al., 2007). The authors con-
cluded that both the P450 epoxygenase and NOS pathways
seem to be involved in the local CBF response to N-methyl-D-
aspartate (NMDA) receptor activation. As in every neuron, NOS
interneurons release potassium (K+), hydrogen ions, and adeno-
sine produced by ATP catabolism in response to neuronal activity
(Iliff et al., 2003).
In addition to releasing various vasoactive mediators, nitrergic
nerves are strategically positioned in proximity to cerebral arter-
ies. NADPHd positive fibers have been found around pial arteries
as well as parenchymal vessels. Pial arteries are innervated by
perivascular nitrergic nerves that originate from sphenopalatine,
otic, and trigeminal ganglia (Suzuki et al., 1994), while fibers
close to parenchymal arteries have been identified as GABAergic
interneurons. NOS interneurons have access to parenchymal arte-
rioles but apparently not to arterioles and arteries proximal to
the Virchow-Robin space (Abadia-Fenoll, 1969; Busija, 1993).
Using electron microscopy, it has been demonstrated that the
axons, dendrites, or somata of NADPHd positive neurons con-
tact the basal membrane of blood vessels or the perivascular
astroglia (Vaucher et al., 2000). As a matter of fact, a very specific
neurovascular connection has been observed in isoled cortical
parenchymal arteries where a network of fibers or individual
fibers is attached along isolated vessels (Estrada et al., 1988).
In a very elegant study, Cauli et al. (2004) identified the sub-
types of interneurons associated with rat cortical microvessels in
layer I–III. According to this study, at a distance within 50μm
of the blood vessels, the percentage of GABAergic neuron sub-
sets appears to be the following: 39% express VIP or NPY, 28%
express NOS, 28% express SOM, some cells co-express more than
one marker. This distribution differed considerably with their
respective density in the same layers and fields of the somatosen-
sory cortex, which was VIP (46.1%) > SOM (30.4%) > NPY
(16.1%) > NOS (7.4%). These results indicate a privileged redis-
tribution of NPY and NOS interneurons in the vicinity of cortical
microvessels. Indeed several authors have reported that cortical
nitrergic neurons are localized in apposition to cerebral arter-
ies, especially in bifurcation areas surrounding vessels with their
projections or sending projections to more distant arterioles and
capillaries (Estrada et al., 1993; Iadecola et al., 1993; Regidor
et al., 1993; Yan et al., 1996). Using infrared videomicroscopy,
Cauli et al. (2004) also demonstrated that the GABAergic neu-
rons not only contacted the neighboring penetrating microves-
sels, but that their dendrites and/or axonal branches reached
for several blood vessels within an area that extended >100μm
away from the cell. In humans, processes of type 1 NADPHd-
positive neurons are also intimately entwined with blood vessels
in the cortex (DeFelipe, 1993; Garbossa et al., 2005) but their
relative vascular and nonvascular distributions have not been
investigated.
FUNCTIONAL SIGNIFICANCE OF THE ANATOMICAL
RELATIONSHIP BETWEEN NOS INTERNEURONS AND
BLOOD VESSELS
NOS interneurons are considered multifunctional as they release
various neuromediators with different physiological effects. This
multifunctionality requires a well-organized anatomy for a high
spatial specificity in NVC. An example of this specificity is the
finding of a distribution of an axonal plexus of densely NADPHd
positive neurons around a restrictive group of microvessels in
human temporal cortex (DeFelipe, 1993). NOS interneurons
co-localize with the very powerful vasoconstrictor NPY in the
cerebral cortex. Neurovascular associations have been reported
for NPY in the human striate cortex (Berman and Fredrickson,
1992). Thus, the local release of NPY through the perivascular
axonal plexus may produce a very localized vasoconstriction that
will provide a spatial limitation to the vasodilation around the
neuronal soma and dendrites (Estrada and DeFelipe, 1998). In
contrast, NO possesses a volume of influence of up to 350μm
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from a source point of production and may in effect dilate vessels
within this radial length (Santos et al., 2012). Another possible
role of NPY in the NOS interneuron-induced vascular response is
to timely limit the vasodilation. Indeed, direct activation of a sin-
gle nitrergic interneuron is sufficient to increase the diameter of a
neighboring microvessel, but reversible dilatation is only induced
by stimulation of a NOS neuron coexpressing NPY (Cauli et al.,
2004).
The role of GABAergic transmission in the control of CBF also
remains obscure, but anatomical and physiological evidences sug-
gest that it could directly act on vessels to induce a vasodilation.
GABA can induce intraparenchymal dilation through GABAa
receptors located on vessels (Fergus and Lee, 1997). Glial cells
also possess GABA receptors (Bureau et al., 1995). It is there-
fore possible that GABAmodulates the vascular tone by acting on
perivascular astrocytes. Consequently, the net effect of GABA on
vascular tone stems from a very complex interaction with vessels,
astrocytes as well as cortical interneurons and pyramidal neurons
receiving GABAergic innervations.
Cortical NOS interneurons receive projections from the basa-
locortical Acetylcholine (Ach) and NO-synthesizing fibers as well
as from the brainstem 5-hydrotryptamine (5-HT) afferents in
both rat and human (Vaucher et al., 1997; Tong and Hamel,
1999). A large proportion (∼30%) of NOS neurons receive both
Ach and 5-HT innervations and 60% of these NOS containing
neurons contact local blood vessels either with their proximal
or distal neurites. Their neuronal processes extend long dis-
tances and contact a broad array of microvessels. NOS neurons
thus appear exceptionally well positioned to relay Ach and 5-HT
afferent information to blood vessels since they also exquisitely
contact neighboring and remotely located blood vessels (Estrada
and DeFelipe, 1998). Nevertheless, studies with 7-nitroindazole
(7-NI), a selective nNOS inhibitor, failed to attenuate the CBF
increase in response to basal forebrain activation (Zhang et al.,
1995; Iadecola and Zhang, 1996). On the contrary, nonselective
NOS inhibitors such as L-NG-nitroarginine (L-NNA) attenuate
the CBF increase induced by stimulation of the basal forebrain
(Raszkiewicz et al., 1992). Ach fibers directly contact corti-
cal microvessels or the surrounding astrocytes in rat and man
(Mesulam et al., 1992; Vaucher and Hamel, 1995; Tong and
Hamel, 1999) and could as a result directly activate eNOS. The
lack of an additive CBF effect of the coapplication of muscarinic
receptor antagonist, atropine, and nonselective NOS inhibitor, L-
NNA, on the cerebral cortex compared to L-NNA alone, suggest
that Ach increases CBF possibly through eNOS activation (Zhang
et al., 1995). In this context, the direct effect of Ach nerves on
the vascular tone may encompass those mediated by nitrergic
interneurons. However, in pathological situations where endothe-
lial functions are altered, NO interneurons may significantly
control CBF following basal forebrain stimulation.
NEURALLY-DERIVED NITRIC OXIDE AND
CEREBROVASCULAR REGULATION
RESTING CEREBRAL BLOOD FLOW
Many evidences suggest that NO plays a role in the cerebrovas-
cular regulation. Various studies demonstrated that systemic or
topical administration of non-selective NOS or selective nNOS
inhibitors decrease resting CBF in many species. This effect is
not observed with the iNOS inhibitor, aminoguanidine (Iadecola
et al., 1995). Intraperitoneal injections of 7-NI, an in vivo
inhibitor of the neuronal isoform of NOS, lower baseline CBF
in unanesthetized rats (laser Doppler on the somatosensory cor-
tex) (Montecot et al., 1997) (autoradiography in the barrel cortex)
(Gotoh et al., 2001a) and anesthetized mice (laser Doppler on the
somatosensory cortex) (Girouard et al., 2007, 2009), cerebral cap-
illary flow in anesthetized rats (intravital microscopy on the right
parietal cortex) (Hudetz et al., 1998), global CBF in anesthetized
rats (autoradiography) (Cholet et al., 1997), and global CBF in
cats (PET scan) (Hayashi et al., 2002a). The decreased cortical
CBF ranges from about 10 to 60% depending on the 7-NI con-
centrations and the cortical areas and it is not accompanied by
a decrease in glucose utilization (Kelly et al., 1995; Cholet et al.,
1997; Hayashi et al., 2002b).
At resting state, arterioles exhibit slow spontaneous rhyth-
mic diameter and blood flow changes of about 0.1 Hz defined
as vasomotion. Vasomotion has been detected in cerebral arter-
ies (Fujii et al., 1990; Filosa et al., 2004) and may be influenced by
a variety of physiological factors including NO (Fujii et al., 1990).
Mathematical models of myogenic mechanisms have demon-
strated that vasomotion oscillations can be propagated locally and
self-sustained within a group feeding of vessels (Behzadi and Liu,
2005). These models also suggest that a vessel with an oscillating
diameter conducts more flow than a vessel with a static diameter
(Meyer et al., 2002). Systemic administration of nonselective NOS
inhibitors lead to the enhancement of oscillations within a com-
mon feeding vessel that are propagated to downstream branches
(Griffith and Kilbourn, 1996; Behzadi and Liu, 2005). However,
this phenomenon may be a consequence of the increase in sys-
temic blood pressure and respiratory rate. The administration of a
nNOS specific inhibitor or the local application of NOS inhibitors
would give more specific information about the role of NO in the
regulation of spontaneous vasomotion.
The CBF reduction in the presence of 7-NI is equivalent to the
CBF attenuation induced by nonspecific NOS inhibitors which
suggests that the neuronal isoform is responsible for the mainte-
nance of resting cerebrovascular tone. Despite this, resting CBF
evaluated with the hydrogen clearance method did not signif-
icantly differ between wildtype, nNOS- and eNOS-null mice
(Atochin et al., 2003). This discrepancy may be explained by com-
pensatory mechanisms in transgenic mice. Another argument for
a neuronal specific effect on resting CBF is that the topical appli-
cation of the specific NMDA receptor antagonist, MK801, reduces
resting CBF to the same extent as 7-NI (Girouard et al., 2009).
This is consistent with a nNOS role in the maintenance of resting
CBF as no functional NMDA receptors in rat and human cere-
bromicrovascular endothelial cells has been identified (Morley
et al., 1998). More importantly, isolated cerebral arteries in a
number of species have not been found to dilate in response to
application of glutamate or NMDA (Faraci et al., 1993; Simandle
et al., 2005) and endothelial damage in vivo failed to affect
NMDA-induced dilation (Domoki et al., 2002). Interestingly,
NOS interneurons are spontaneously active. These spontaneous
spikes are likely to be initiated by a baseline NMDA recep-
tor activity detectable during subthreshold synaptic activation
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(Katona et al., 2011). It is thus possible that NOS interneuron
spontaneous activity participates to maintain a certain level of
resting CBF.
Anatomical and physiological evidences suggest the presence
of nNOS in arterial smooth muscle. Neuronal NOS has been
found in smooth muscle of cerebral vessels (Toda and Okamura,
2011) as well as in the common carotid artery (Brophy et al.,
2000). In addition, 7-NI increases contractile response of carotid
artery (Brophy et al., 2000). These results brought controversies
about the origin of NO that contributes to the maintenance of
resting CBF. However, in Brophy’s study, 7-NI was applied on iso-
lated arteries whereas 7-NI acts as a preferential nNOS inhibitor
when administered systemically only (Babbedge et al., 1993).
Using electron microscopy, Wang et al. (2005) did not observe
any nNOS in vascular smooth muscle cells, endothelium, or glial
processes.
Assuming that NO contributing to the resting CBF comes
from neurons, the neuronal subtype responsible for its formation
still has to be clearly identified. Although a clear participation
of nitrergic nerves from the pterygopalatine ganglion has been
demonstrated in the dilation of the middle cerebral artery and
the posterior communicating arteries (Toda andOkamura, 2003),
no studies have identified the specific neuronal NO origin that
control parenchymal arteries tone. The use of Cre-dependent
optogenetic transgenic mice for light induced activation and
silencing different types of neurons will be necessary to clarify this
issue (Madisen et al., 2012).
AUTOREGULATION
Cerebrovascular resistance decreases or increases in response to
changes in transmural pressure and blood flow so that flow
remains constant. Changes in resistance result from vasodilation
and vasoconstriction of the pial and parenchymal vessels (Shapiro
et al., 1971). Several studies have investigated the role of NO
in the mechanisms involved in autoregulation. Nonspecific NOS
inhibitors were administered while arterial pressure was decreased
in a stepwise manner in order to test the role of NO in the lower
limit of autoregulation. Although data coming from these stud-
ies were divergents the lower limit of autoregulation was raised
in eNOS knockout mice (Huang et al., 1994) and remained nor-
mal in nNOS knockout mice (Huang et al., 1996). In addition, a
study showing nonspecific NOS-induced autoregulation dysfunc-
tion failed to demonstrate similar effects with the nNOS inhibitor
7-NI (Toyoda et al., 1997) suggesting that eNOS is involved in
the vasodilation in response to decreases in arterial pressure. To
test the upper limit of autoregulation, arterial presure is gradualy
elevated. Contrasting results emerged from studies using nonspe-
cific NOS inhibitors. No effects have been observed with 7-NI
(Hardy et al., 1999). Although many questions remain unresolved
concerning the effect of NO in the control of autoregulation,
there are no indications that (inter)neurons are involved in these
mechanisms.
HYPERCAPNIA AND HYPEROXIA
CBF is highly sensitive to alterations in arterial blood gases.
For instance, increases in the partial pressure of arterial CO2
(PaCO2) and O2 (PaO2) provoke dilation and constriction,
respectively. In several mammalian species including humans,
it has been reported that blockade of NO synthesis with NOS
inhibitors attenuates CBF responses to hypercapnia (Iadecola,
1992; Wang et al., 1992; Buchanan and Phillis, 1993; Pelligrino
et al., 1993; Iadecola and Xu, 1994; Iadecola and Zhang, 1994;
Sandor et al., 1994; Heinert et al., 1999) in the entire brain
(Bonvento et al., 1994). The participation of NO is more impor-
tant in mild hypercapnia (PaCO2 = 50–60mm Hg) (Iadecola
and Zhang, 1994). The cellular sources of NO during hyper-
capnia remain to be established but some evidences suggest a
role for nNOS-derived NO in vascular responses to hypercapnia.
Hypercapnia increases nNOS-derived NO in rat brain (Harada
et al., 1997). Administration of 7-NI reduces the vasodilator
and CBF responses to hypercapnia in anesthetized rats, suggest-
ing that NO synthesized by nNOS participates in hypercapnic
hyperemia (Wang et al., 1995; Okamoto et al., 1997). Endothelial
denudation does not alter basilar and middle cerebral artery
dilation in Japanese monkeys and Mongrel dogs in response to
moderate hypercapnia (Toda et al., 1996). However, light/dye
endothelial injury as well as NOS and soluble guanylate cyclase
inhibition reduce hypercapnic cerebrovascular dilatation in anes-
thetized juvenile pigs, indicating that endothelial NO may play a
significant role in the hypercapnic vasodilatation in this model
(Willis and Leffler, 2001). Thus, mostly nNOS-derived NO seem
to participate in the vascular response to hypercapnia while both
eNOS and nNOS derived NO may participate in the autoregula-
tion of the particular piglet cerebrovascular regulation.
The mechanisms by which NO modulates the hypercanic vas-
cular response are not clear. However, hypercapnia provokes H+
accumulation and acidosis which, by converting Ca2+ waves to
sparks, leads to the activation of BK(Ca2+) channels to induce
dilation of cerebral parenchymal arteries (Dabertrand et al.,
2012). This effect may be amplified by the modulating effect of
NO on large conductance Ca2+-dependent K+ (BK) channels.
This is consistant with the presence of hypercapnic vasodilation in
isolated arteries in concert with NOS participation in the acidosis-
induced vasodilation (Niwa et al., 1993) and the permissive role
of NO in hypercapnic vasodilation (Iadecola and Zhang, 1994).
Hyperoxia causes a transient decrease in CBF, followed by a
later rise. From mice lacking nNOS or eNOS and wild-type mice,
Atochin et al. (2003) obtained evidences suggesting that cerebral
vasodilatation induced by 60-min exposure to hyperbaric oxy-
gen depends on both nNOS and eNOS. However, the underlying
mechanisms remain to be investigated.
NEUROVASCULAR COUPLING
Active neurons send various signals to astrocytes and blood
vessels in order to increase CBF and obtain sufficient O2 and sub-
strates. A number of studies have provided evidences that NOS
inhibition attenuates the CBF increase in response to neuronal
activity. Indeed, local application of NOS inhibitors suppresses
the activity-dependent vasodilation by about 50% (Dirnagl et al.,
1994; Irikura et al., 1994; Peng et al., 2004; Girouard et al.,
2007; Kitaura et al., 2007). Systemic administration of 7-NI
has also been shown to reduce the amplitude of NVC in dif-
ferent experimental paradigm of neuronal activation such as
whisker stimulation and electric stimulation of mice forepaw
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(Cholet et al., 1996; Bonvento et al., 2000; Girouard et al., 2007;
Liu et al., 2008). In both eNOS and nNOS-knockout mice,
activity-dependent vascular changes were similar to those in
control mice. However, in eNOS null mice, activity-dependent
vasodilation was suppressed byNOS inhibitors (Ayata et al., 1996)
while in nNOS knockout mice, NVC remained intact in the pres-
ence of NOS inhibitors (Ma et al., 1996). These data support the
participation of neurogenic NO in NVC.
Reports on awake animals brought controversies about the
role of NO on NVC. Studies with nonspecific NOS inhibitors,
in which CBF was quantitatively determined in unanesthetized
restrained animals, have failed to support such a role for NO
(Sokoloff et al., 1992;Wang et al., 1993; Adachi et al., 1994). These
results conclude that NVC is modulated by NO in anesthetized
conditions only. However, in unanesthetized unrestrained rats,
unspecific and specific nNOS inhibition decreases the vascular
response to neuronal stimulation (Gotoh et al., 2001b). This
discrepancy could be explained by the fact that immobilization
of animals is a stressful condition that lowers paCO2, increases
circulating catecholamines and therefore alter cerebrovascular
regulation (Lacombe and Seylaz, 1984).
Another aspect that may mislead data interpretations is the
potential effect of NO on neuronal activity (Lonart et al., 1992;
Manzoni and Bockaert, 1993; Schuman and Madison, 1994;
Jayakumar et al., 1999) that could explain its effect on NVC. Some
studies have shown a decreased amplitude of somatosensory-
evoked potentials induced by electrical stimulation of the forepaw
or the sciatic nerve in the presence of NOS inhibitors (Ngai et al.,
1995; Stefanovic et al., 2007). Other investigations demonstrated
that NOS inhibition has no significant effect or a very slight effect
on somatosensory evoked potentials (Lindauer et al., 1996; Burke
and Buhrle, 2006; Hoffmeyer et al., 2007) or cerebral glucose
activation (Cholet et al., 1997). Notwithstanding the observed
effects on activated potentials, NOS inhibition was always accom-
panied by CBF reduction in in situ electrical response to neuronal
supporting a role in the modulation of the vascular response.
Local NOS interneuron density varies among brain areas.
Consequently, in each region, CBF may be differently regulated
by NO. Cholet et al. reported that NO plays a role in NVC
in the somatosensory area and the thalamus but less so in the
trigeminal primary nucleus in rats under peri-oral somatosensory
stimulation (Cholet et al., 1997). During vibrissal stimulation
in unanesthetized rats, NOS inhibition with L-NAME attenu-
ates the increase in CBF in the ventroposteromedial thalamic
nucleus and 7-NI reduces the CBF in both the ventroposterome-
dial thalamic nucleus and the barrel cortex. NOS inhibitors did
not significantly affect CBF in the spinal trigeminal nucleus and
the principal sensory trigeminal nucleus (Gotoh et al., 2001a).
Electrical somatosensory stimulation in the unilateral cat forepaw
elicits an increase in CBF in the contralateral somatosensory cor-
tex and the ipsilateral cerebellum which is attenuated by 7-NI
(Hayashi et al., 2002b). These results are consistent with NOS
interneuron distribution and strongly support the idea that NO
regulating CBF comes from GABAergic neurons (Bertini et al.,
1996; Mize et al., 1996).
CBF responses reflect the combined activities of cells and
synapses that include both excitatory and inhibitory processes.
Hence, depending on the afferent pathway and intensity, dis-
tinct population of neurons may be recruited. Electrical stimu-
lation of two different pathways—cortico-cortical (transcallosal)
or thalamocortical (infraorbital)—results in increased cortical
CBF associated with the recruitment of distinct populations
of interneurons and cyclo-oxygenase (COX)2 pyramidal cells
(Enager et al., 2009). Analysis of double-immunostained cells
with c-Fos and specific neuronal markers indicate that after
4Hz thalamocortical stimulation, activation of COX2 express-
ing pyramidal cells and specific subtypes of inhibitory GABA
interneurons that contain PV and SOM, a subset of the latter, are
also known to contain NOS (Kubota et al., 1994). Transcallosal
stimulation at 4Hz sollicitates more COX2 pyramidal cells and
less SOM interneurons (Enager et al., 2009). However, at 30Hz, a
larger fraction of SOM-NOS interneurons were activated together
with a subset of VIP interneurons, but there was a silencing of
those containing PV. Blood flow responses to these stimulations
show a strong correlation between the CBF amplitude and the
percentage of the SOM eNOS subset of GABAergic interneurons
recruited (Enager et al., 2009).
The NO release from (inter)neurons is stimulated by gluta-
matergic neurotransmission (Faraci and Breese, 1993). Glutamate
binds to its NMDA ionotropic receptors to produce NO by the
activation of nNOS, an enzyme tethered to the NMDA recep-
tor NR1 subunit receptor complex by the post-synaptic density
protein-95 (Christopherson et al., 1999). This is consistent with
the presence of nNOS in post-synaptic dendrites (Wang et al.,
2005), NMDA R1 subunit mRNA or immunoreactivity in the
majority of nNOS-immunoreactive neurons in rat cerebral cor-
tex (Price et al., 1993). Ionotropic NMDA receptor stimulation
results in Ca2+ influx, membrane depolarization, activation of
nNOS, and the subsequent production of NO, which diffuses out
of the neurons and acts on smooth muscle cells in local arteri-
oles and pial arteries to cause vasodilatation (Faraci and Brian,
1995; Meng et al., 1995; Pelligrino et al., 1996; Garthwaite et al.,
1989a; Girouard et al., 2009). NO may also directly act on per-
icytes surrounding terminal arterioles and capillaries (Hamilton
et al., 2010).
The hypothesis that the nNOS-induced activation by NMDA
receptors contributes to the increase in CBF is supported by
the following observations: (1) NMDA increases NO produc-
tion around arteries as demonstrated by the accumulation of NO
degradation products in the cerebrospinal fluid surrounding the
arteries (Domoki et al., 2002) or directly in the arteries (methe-
moglobin detection by spectroscopy) (Gonzalez-Mora et al.,
2002) following NMDA application in the cortex and the simul-
taneous increase in CBF and NO production measured using
microdialysis after NMDA perfusion in the striatum (Bhardwaj
et al., 2000). (2) Both dilation and NO increases induced by
NMDA are reduced by treatment with nonspecific and specific
nNOS inhibitors in various animal species (Faraci and Breese,
1993; Faraci and Brian, 1995; Meng et al., 1995; Bhardwaj et al.,
2000; Gonzalez-Mora et al., 2002). (3) These effects are abolished
by the administration of the sodium channel blocker tetrodotoxin
(TTX), an agent which does not usually affect the endothelium
(Faraci and Breese, 1993; Pelligrino et al., 1996) whereas endothe-
lial stunning by phorbol 12,13-dibutyrate leaves NMDA-induced
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dilation intact (Domoki et al., 2002). Exception has been found
in the piglet which seems to be the unique model expressing
ionotropic glutamate receptors in the endothelium and where
dilator responses of cerebral resistance vessels to glutamate were
reported to be intact despite the presence of TTX (Leffler et al.,
2006). (4) Tissue plasminogen activator (tPA) is critical to the full
expression of the flow increase evoked by activation of the mouse
whisker barrel cortex and increases NMDA-induced NO pro-
duction by increasing nNOS phosphorylation state (Park et al.,
2008).
Differential recruitment of ionotropic glutamatergic recep-
tors (GluRs) seems to result from different stimulation frequen-
cies. Indeed, ionotropic nNOS inhibition reduces CBF responses
to all stimulation frequencies by 50% (Dirnagl et al., 1993;
Hoffmeyer et al., 2007) while NMDA receptor blockade attenu-
ates CBF responses only at high frequencies. This suggests that
nNOS activity may be stimulated by NMDA-independent mech-
anisms. This could involve gating of Ca2+ permeables AMPA
or kainate receptors as well as opening voltage sensitive Ca2+
channels (Goldberg and Yuste, 2005). Application of kainate
and AMPA receptor agonists also results in NO production
(Garthwaite et al., 1989b; Bhardwaj et al., 1997a) and dilation
of cerebral arteries in all species studied when applied to the
cerebral cortex. Dilation to kainate is attenuated by inhibition
of NOS (Faraci et al., 1994). It also appears that antagonists or
blockers of heme oxygenase and COX reduce dilation to kainate
(Bari et al., 1997; Ohata et al., 2006) or to the kainate recep-
tor agonist, (RS)-2-amino-3-(3-hydroxy-5-t-butylisoxazol-4-yl)
propionic acid (ATPA) (Robinson et al., 2002). Arterial dilation
to AMPA is not restricted by superfusion of NOS inhibitors but
is attenuated by adenosine A(2A) and A(2B) receptor antagonists
and the HO inhibitor chromium mesoporphyrin (Ohata et al.,
2006).
Although glutamate has the potential to induce vasodilation
though activation of any of the three ionotropic glutamate recep-
tors, this effect mostly involves NMDA receptors. Thus, MK-801,
a selective NMDA receptor antagonist, blocks almost all of the
cerebral dilator response to glutamate or NMDA in rabbits,
piglets, and rats (Faraci and Breese, 1993; Meng et al., 1995;
Pelligrino et al., 1995, 1996; Girouard et al., 2009). This prefer-
ence for the NMDA receptors in the cortex may be due to their
location in the cerebral cortex or due to their greater affinity for
glutamate than kainate or AMPA receptors.
In the mouse somatosensory cortex, serotonin 5-HT3A recep-
tors have been identified in neurogliaform like regular spiking
neurons corresponding to GABAergic neurons expressing NPY
and NOS (Vucurovic et al., 2010; Markwardt et al., 2011).
This receptor, which is the only ionotropic serotonergic recep-
tor (Chameau and van Hooft, 2006), mediates fast serotonin-
induced excitation (Ferezou et al., 2002). Perrenoud et al. (2012a)
found that activation of 5-HT3A-expressing interneurons mostly
induces NO-mediated vasodilation and, less frequently, NPY-
mediated vasoconstriction. The same study also demonstrated
that these effects are absents in Pet-1 knock-out mice which dis-
play a drastic depletion of cortical serotoninergic fibers (Kiyasova
et al., 2011) supporting NPY/NOS interneuron-dependent
vasomotor effects rather than presynaptic 5-HT3 activation of
serotonergic axons originating from the raphe nuclei. According
to Perrenoud et al. (2012a) activation of the serotonin 5-HT3A
receptors triggers NPY and NO release by a mechanism inde-
pendent of action potential generation, but rather by direct Ca2+
influx which may induce Ca2+ release from intracellular stores.
NO is one of the vasodilator that diffuses the most rapidly
(Wood and Garthwaite, 1994) and its release, in the context of
NVC, mostly depends on nNOS activation. The release of NO
from neurons depends on intracellular Ca2+ elevation similar
to other vasoactive mediators derived from neurons (Lauritzen,
2005) and astrocytes (Straub and Nelson, 2007). Thus, a fast
activation of nNOS would occur following Ca2+ influx after
fast neuronal depolarization (10–12ms) (Petersen et al., 2003)
and/or activation of ionotropic receptors while a slower release
may be induced through the activation of metabotropic recep-
tors leading to Ca2+ release from intracellular stores (Perea and
Araque, 2005). Thus, hypothetically, NOmay account for the ini-
tiation and the maintenance (up to 15min) of the vasodilatatory
response in NVC. This premise is supported by the following
observations: (1) NO concentrations increase at the beginning
of the stimulation and remain elevated during at least a 2min
duration of neuronal stimulation (de Labra et al., 2009); (2) CBF
responses to 1 s stimulation of the mouse hindpaw is reduced by
about 50% in nNOS knockout mice or after topical application
of L-NA (Kitaura et al., 2007); (3) Topical application of L-NNA
dampers the entire NVC; (4) Systemic administration of 7-NI
attenuates NVC during long stimulus of more than 60 s (Dirnagl
et al., 1993, 1994; Ngai et al., 1995; Lindauer et al., 1999; Peng
et al., 2004). NO can either act directly on smooth muscle cells
through the guanylate cyclase/cGMP system or indirectly by hav-
ing a permissive role. In the cerebral cortex, the reduction of
the magnitude of the NVC reduced by NOS inhibition could be
restored by the normalization of basal NO levels with the infusion
of the NO precursor, L-arginine NO (Northington et al., 1992;
Lindauer et al., 1999). This effect is not observed after restoration
of basal cGMP levels. These observations suggest that, in the cor-
tex, NO is a modulator rather than a mediator of NVC (Iadecola
et al., 1994; Lindauer et al., 1999). However, the vasodilation
induced by NMDA is completely dependent of nNOS, guany-
late cyclase, and protein kinase G (Girouard et al., 2009) which
indicates that NO has an obligatory role in the NMDA-induced
dilation and thus possibly in the fast ionotropic dependent CBF
response to neuronal activation.
In summary, it seems that an initial rise of intracellular NO
concentration in interneurons following activation of the gluta-
matergic or serotoninergic ionotropic receptors is responsible for
the initiation of the vascular response whereas during long stim-
ulation, NO would have a permissive role for other mediators to
increase CBF.
ROLE OF ASTROCYTES IN THE NO MODULATION OF
NEUROVASCULAR COUPLING (FIGURE 1)
Astrocytes are key elements in the neural activity-dependent
regulation of vascular tone. Anatomically, astrocytes surround
most of the arteriolar and capillary abluminal surface with
their endfeet and are uniquely positioned between synapses
and vessels. This specific arrangement led to the concept of
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FIGURE 1 | Nitric oxide (NO) interactions in neurovascular coupling
(NVC). NO may be released from red blood cells, endothelial cells, smooth
muscle cells, astrocyte, interneurons, and some pyramidal cells. NO may be
involved in the initiation of NVC through a cyclic guanosine monophosphate
(cGMP)-dependent pathway and may modulate NVC probably by interaction
with different cGMP-independent pathways. In astrocyte, glutamate released
from pyramidal cell binds to the metabotropic glutamate receptor (mGluR)
which lead to IP3 formation and the subsequent release of Ca2+. The
increase in intracellular Ca2+ activates BK channel and catalyses the
phosphorylation of arachidonic acid (AA) by phospholipase A2 (PLA2).
AA metabolites (PGE2, 20-HETE, and EET) will mediate cerebral blood flow
(CBF) through different pathways. NO may interact with different astrocytic
pathways such as Ca2+ release, Ca2+-activated K+ channel (BK) opening, and
COX1 activity. NO can also decrease 20-HETE formation through the
inhibition of CYP4A. Vascular smooth muscle cells are the final integrators of
NO-induced signals coming from the endothelium, the blood, neurons, and
astrocytes. In the SMC, NO directly mediate vasodilation through the
increase in cGMP-PKG activity and the increase of BK channel opening
probability and the subsequent hyperpolarization as well as the inhibition of
RhoA phosphorylation. The contractile state of VSMC is mainly determined
by the phosphorylation level of myosin light chains (MLC). MLC is
phosphorylated by the Ca2+/calmodulin-dependent MLCK and
dephosphorylated by the Ca2+-independent MLCP. NOS may be inhibited,
in turn, by RhoA kinase (ROCK).
a neuron-astrocyte-vasculature tripartite (Vaucher and Hamel,
1995). Functionally, astrocytes can integrate neurotransmitters
signals from thousands of synapses (Bushong et al., 2002) and
relay this information to the arterioles (Metea and Newman,
2006). Surely, results obtained in cortical brain slices show a tem-
poral link between increases in Ca2+ in the astrocyte and the
subsequent vasodilation of neighboring arterioles (Zonta et al.,
2003a). Then, using two-photon microscopy, Nedergaard’s team
(Wang et al., 2006) confirmed in vivo the physiological involve-
ment of astrocytic Ca2+ increase in NVC. In accordance with
the functional studies, metabotropic GluRs blockers attenuate the
astrocytic Ca2+ signal indicating that astrocytes sense and get
activated by glutamate. The involvement of astrocytes is likely to
occur in the late phase of NVC. Indeed, Calcinaghi et al. (2011)
reported that pharmacological blockage of mGluR5 and mGluR1
mostly expressed on astrocytes (Porter andMcCarthy, 1996) does
not affect NVC in the somatosensory cortex of adult rats on brief
whisker stimulation of 4 and 24 s. Whisker stimulation in vivo
induces CBF increase after 600ms (Devor et al., 2003) while it
activates astrocytes with a latency of 3 s after the stimulus (Wang
et al., 2006). In situ electrical stimulation within the barrel trig-
gered astrocyte Ca2+ transients, which peaked within 1–2 s after
stimulation (Schipke et al., 2008). These data strongly suggest
that although astrocytic Ca2+ rises early after neuronal activa-
tion, astrocytic metabotropic activation does not play a significant
role in the onset of CBF but is essential for the maintenance of
the hemodynamic response during NVC. In addition, the lack
of an astrocytic Ca2+ rise when neuronal activity is blocked by
TTX, indicates that neurons and astrocytes act in series during
the delayed phase of NVC.
Some evidences support the hypothesis that NO derived
from nNOS participates in the mGluRs induced CBF
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increase. The mGluR1 and five agonist, trans-1-amino-1,3-
cyclopentanedicarboxylic acid (ACPD), is capable of increasing
NOS activity in vivo through an IP3-dependent mechanism
(Bhardwaj et al., 1997b). In addition, nNOS inhibition strongly
attenuates the CBF increase to the mGluR1 activation with the
agonist (S)-3,5-dihydroxyphenylglycine (DHPG) during the first
10–15min of superfusion while it does not exert any significant
effect after 15min (Liu et al., 2011). These data suggest that
NO interact with different astrocytic pathways instead of acting
directly on smooth muscle cells. In the next paragraphs, we will
describe the possible interaction of NO with different pathways
involved in NVC.
REPORTED EFFECTS OF NO ON ASTROCYTIC Ca2+ SIGNALING,
BK AND PLA2 PATHWAYS
For decades, investigators assumed that NO originating from
neurons diffuses to smooth muscle cells to induce a vasorelax-
ation. However, astrocytes are anatomically closer to neurons and
nNOS than smooth muscle cells. In addition, an increased cGMP
production has been observed in astrocytes in response to exoge-
nous NO as well as to glutamate andNMDA induced NO produc-
tion (Malcolm et al., 1996). Willmott et al. (2000a) demonstrated
that NO-PKG signaling is coupled to Ca2+ mobilization in iso-
lated glial cells. In many cellular types, it has been demonstrated
that NO induces Ca2+ mobilization (Publicover et al., 1993;
Willmott et al., 1995a,b; Clementi et al., 1996) through the acti-
vation of the cGMP-PKG and ADP-ribosylcyclase and subsequent
increase in synthesis of the potent Ca2+ ryanodine receptor (RYR)
dependent mobilizing agent cyclic ADP-ribose (Galione et al.,
1991; Willmott et al., 1995b; Clementi et al., 1996) or the direct
nitrosylation of regulatory thiol groups of RYR (Stoyanovsky
et al., 1997).
Cytoplasmic and endoplasmic reticulum (ER) Ca2+ are
important determinant of IP3-mediated Ca2+ release, which
delivers local Ca2+ in astrocytic endfeet for BK channel activation
in the endfeet. The release of K+ into the arteriolar space acts on
smooth muscle inward rectifying K+ channels to hyperpolarize
the smooth muscle cell membrane, lower arteriolar smooth mus-
cle [Ca2+] and thereby cause vasodilation (Straub et al., 2006).
In several tissues, the cGMP/PKG pathway activates BK channels
(Archer et al., 1994; Alioua et al., 1995; Carrier et al., 1997). BK
channel activity is regulated by a variety of signaling molecules,
including intracellular Ca2+ ([Ca2+]i) (Kume et al., 1989), pro-
tein kinases (Robertson et al., 1993), tyrosine kinases (Alioua
et al., 2002), cytochrome P-450 metabolites of arachidonic acid
(Zou et al., 1996), and heme (Tang et al., 2003). BK channels are
also directly activated by O2, CO, andNO as demonstrated in cell-
free membrane patches isolated from the intracellular medium
(Bolotina et al., 1994). Thus NO may modulate BK channel
opening directly or by inducing cytosolic Ca2+ increase. BK chan-
nels are typically composed of pore-forming α subunits that are
encoded by the Slo1 (orKCNMA1) gene, and accessory ß subunits
that modulate channel gating (Tanaka et al., 2004). Stimulatory
effect of NO on BK channels is likely mediated by the β subunits
of BK channel complex. NO elevates BK channel Ca2+ sensitivity
(Tanaka et al., 2004), enhancing the effective coupling of Ca2+ to
BK channels (Jaggar et al., 2002).
The level of Ca2+ in astrocytic endfeet determines the nature
of the vascular response with moderate elevations causing dila-
tion and larger elevations causing constriction. The constrictive
responses in preconstricted arteries in brain slices incubated in
artificial cerebrospinal fluid with stable levels of oxygen seem
to be entirely dependent on BK channels (Girouard et al.,
2010). In acute mammalian retina, high doses of the NO donor
SNAP (100μM) blocks light-evoked vasodilations or transforms
vasodilations into vasoconstrictions. This effect is prevented with
PTIO (a NO scavenger, 2-pyenyl-4,4,5,5-tetramethylimidazoline-
3-oxide-1-oxyl). In the presence of L-NAME, light stimulation
evokes only vasodilations. All arterioles dilate in response to light
when NO is lower than 70 nM. At NO concentrations between
80 nM and 1μM, light-evoked responses switch from dilation
to constriction (Metea and Newman, 2006). Electrical stimula-
tions in brain slices raises NO concentration up to 100 nM as
measured by electrodes (Shibuki and Okada, 1991) and levels
up to 1–4μM have been measured in rat brain in vivo during
ischemia and reperfusion (Malinski et al., 1993). In this context,
the NO induced vasoconstriction is probably pathological. The
NO capacity to mobilize astrocytic Ca2+ and to increase BK chan-
nels opening probability may explain why exogenous NO could
transform vasodilation into vasoconstriction and support the idea
of a modulating role of NO in NVC (Figure 2).
Astrocytic cytosolic Ca2+ induces arachidonic acid release
(Alkayed et al., 1997), which serves as a substrate for the synthesis
of epoxyeicosatrienoic acids (EETs) by CYP2C and CYP2J epoxy-
genases in astrocytes (Alkayed et al., 1996, 1997; Nithipatikom
et al., 2001; Peng et al., 2004), prostaglandin E2 (PGE2) by
COX1 in astrocytes (Zonta et al., 2003b), and the synthesis of
20-HETE by CYP4A enzymes in cerebral vascular smooth muscle
(Dunn et al., 2008). Astrocyte-derived EETs promote increases in
astrocyte Ca2+ and opening of astrocytic BK channels (Yamaura
et al., 2006). They may also diffuse from astrocytes to the adja-
cent smooth muscle cells to open BK channels and hyperpolarize
vascular smooth muscle cells (Alkayed et al., 1997). Specific
inhibitors of EET synthesis, MS-PPOH andmiconazole, or antag-
onist of EET receptors, 14,15-EEZE, show that EETs contribute to
40–60% of the CBF response to sensory stimulation (Liu et al.,
2011). In contrast, 20-HETE depolarizes smooth muscle cells by
inhibiting the opening of K+ channels (Lange et al., 1997) and
enhances Ca2+ influx through voltage-dependent Ca2+ channels
(Gebremedhin et al., 1992). The 20-HETE inhibitor HET0016
blocks the vasoconstriction elicited by electrical activation in rat
brain slices (Hama-Tomioka et al., 2009). In vivo, HET0016 atten-
uates the CBF response during the first 5min of activation of
the group I mGluRs with DHPG superfusion, suggesting that
20-HETE might serve as a vasodilator during the first phase of
the group I mGluR-induced vasodilation (Liu et al., 2011). This
effect may be explained by the conversion of 20-HETE to the
vasodilator 20-hydroxy-PGE by COX (McGiff and Quilley, 1999).
When mGluR activation is prolonged beyond 30min, the inhi-
bition of 20-HETE synthesis prevents the decrement of the CBF
suggesting that this mediator may limit CBF increase periods
(Liu et al., 2011). The other arachidonic acid metabolite, PGE2
released from astrocytes may travel to smooth muscle cells and
induce vasodilation by binding to EP4 prostaglandin receptors
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FIGURE 2 | Hypothetical mechanisms underlying the biphasic effect of
NO in the modulation of NVC. A moderate or physiological NO increases
the release of vasorelaxing factors from the astrocyte and depolarise smooth
muscle cells to increase cerebral blood flow. NO levels above 70–80 nM may
increase astrocytic Ca2+ mobilization and BK channel opening probability to a
level that will increase the perivascular K+ ion concentrations over 20mM.
Such a high K+ concentration induces smooth muscle membrane
depolarization and the consequent vasoconstriction.
(Davis et al., 2004), which increase the activation of protein kinase
A by cyclic AMP and as a result decrease the phosphorylation of
the myosin light chain (Takata et al., 2009).
NO can affect vasomotor responses by inhibiting
ω-hydroxylase, the synthetic enzyme for the vasoconstrictor
20-HETE (Roman, 2002). It also enhances prostaglandin pro-
duction by COX1 (Fujimoto et al., 2004). The concomitant
inhibition of the synthesis of the vasoconstrictor 20-HETE and
COX1 expressed in astrocytic endfeet (Gordon et al., 2008) stim-
ulation by NO may underlie a significant fraction of the dilating
effect of NO (Sun et al., 2000) and may be another mechanism by
which NOmodulates NVC in a cyclic GMP-independent manner.
Also, by counteracting the decrement of CBF by 20-HETE at the
end of the stimulation, NO could increase the length of the CBF
response.
NO can also enhance the catalytic activity of COX2 in the brain
(Salvemini, 1997). However, although COX1 is present in astro-
cytes, COX2 is rather present in neurons post and presynapticaly
to nNOS neurons (Bidmon et al., 2001). Anatomical evidences
suggest a close interaction between COX2 and NO. Firstly, COX2
and nNOS are both prevalent in layer I and III, IV (Degi et al.,
1998). Secondly, COX2 are detected in dendrites that are lightly
immunolabeled for nNOS. Both COX2 and nNOS are close to
walls of penetrating arterioles and capillaries and separated by
thin glial processes (Wang et al., 2005), which indicate that their
interaction may play a role in the regulation of NVC. However,
physiological studies have shown an additive effect with unspe-
cific COX and NOS inhibitions (Kitaura et al., 2007), suggesting
independent pathways.
RETROGRADE VASODILATATION (FIGURE 3)
During NVC, local vasodilation must be associated with dila-
tion of upstream pial arteries (Duling et al., 1987). This has been
observed in several brain areas. For example, activation of whisker
barrel cortex increases vascular diameter in pial arterioles that
are several hundred micrometers away from the site of activa-
tion (Ngai et al., 1988; Cox et al., 1993; Erinjeri and Woolsey,
2002). Several possible mechanisms have been proposed for this
complex and coordinated chain of events, including widespread
neurovascular innervation, propagation of astrocytic Ca2+ waves
and “intramural” signaling within the vascular wall. Vascular
smoothmuscle cells probably receive and integrate signals coming
from neurons, glia, endothelial cells as well as mechanical forces.
Indeed, neurons release NO, glutamate, and ATP that have been
shown to play a role in the astrocytic Ca2+ wave propagation. NO
is a good candidate for the propagation of neuronal signals since
it can diffuse very rapidly and propagate to a distance of up to
100μM. NO can also potentiate the propagation by amplifying
the astrocytic signals such as Ca2+ waves and ATP and glutamate
release from astrocytes. Indeed, the addition of puffs of aqueous
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FIGURE 3 | Proposed mechanisms by which NO interneurons may
propagate the signal in the cortex. Two parenchymal descending arteries
(left and right of the figure) are branching from a pial artery. Astrocytes (light
green cells) cover descending arteries with their specialized projections: the
astrocytic endfeet, with the exception of the pial artery and parenchymal
arteries portion separated by the Virchow–Robin space. Following local
neuronal activity, pyramidal cells (black cells) stimulate nitrergic interneurons
(blue cell), through their glutamate NMDA receptors. The influx of calcium
(Ca2+) in the cell allows activation of the neuronal NO synthase (nNOS) and
the production of NO. NO diffuses freely through cell membranes and
reaches the astrocytic endfeet where it could modulate the release of various
vasoactive metabolites. NO may be involved in retrograde vasodilation either
through astrocyte signaling modulation or by acting directly on smooth
muscle cells. Indeed NO can increase the release of ATP and glutamate from
astrocytes. ATP released from vesicles goes from one astrocyte to the next
stimulating P2Y purinergic receptors, creating a Ca2+ wave. These Ca2+
waves enhance the production of arachidonic acid (AA) derived vasodilation
mediators like epoxyeicosatrienoic acids (EETs) or activate large conductance
Ca2+-dependent K+ channels thus causing arterial vasodilation. NO also
directly increases astrocytic Ca2+ and might therefore facilitate the
production of vasodilators. Finally, NO binds to smooth muscle guanylate
cyclase and increases the cGMP levels. Stimulated nitrergic interneurons also
release GABA which could act either on astrocytes or smooth muscles
GABA-A receptors to cause vasodilation. However, GABA seems to restrain
the astrocytic signal propagation. Simultaneously, Neuropeptide Y (NPY) is
released most probably to a remote vascular bed (on the left of the
illustration) to cause a vasoconstriction and concentrate the blood flow close
to the neuronal activation.
NO induces large astrocytic Ca2+ transients that propagate to
a group of up to 20 cells (Willmott et al., 2000b). This effect
seems to be mediated through PKG and RyR-linked Ca2+ release
as well as gap junction (Bolanos and Medina, 1996; O’Donnell
and Grace, 1997). Astrocytes are known to have a vesicular pool
of glutamate (and possibly ATP) that is rapidly exocytosed in
response to agonists such as NO that raise intracellular Ca2+
(Maienschein et al., 1999; Pasti et al., 2001). Nanomolars levels
of ATP can act via extracellular mediators and may carry infor-
mation between astrocytes (Scemes, 2000). NO is also known to
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cause rapid glutamate release from neurons (Meffert et al., 1994).
Thus NO may propagate the neuro-astrocytic signals directly by
increasing intracellular concentrations of Ca2+ or through the
release of ATP and glutamate. ATP may also be metabolized and
produce adenosine, a potent vasodilator. Adenosine has long been
implicated as a mediator of NVC (Ko et al., 1990; Dirnagl et al.,
1994). Indeed, adenosine A2A receptors have a role in dilation of
upstream pial arterioles during neuronal activation or direct acti-
vation of GluRs (Iliff et al., 2003; Ohata et al., 2006). In addition
to acting on vascular adenosine receptors, adenosine could act on
astrocytes, which also express various types of adenosine recep-
tors (Fields and Burnstock, 2006). Activation of A2B receptors can
increase intracellular Ca2+ in astrocytes and might participate
in the propagation of increased Ca2+ throughout the astrocyte
processes (Pilitsis and Kimelberg, 1998). Ordinarily, an increase
in Ca2+ is associated with release of ATP through connexin
hemichannels, and A2B receptors potentiate the ATP-evokedCa2+
response (Jimenez et al., 1999; Alloisio et al., 2004). Finally,
the release of GABA from interneurons restricts the astrocytic
response to the barrel column (Benedetti et al., 2011).
Endothelial and smooth muscle cells in the brain are con-
nected by homocellular gap junctions and can propagate vasodi-
lation in a retrograde fashion (Dietrich et al., 1996; Sokoya
et al., 2006). Local vasodilation increases flow velocity in
upstream branches which, due to increased shear stress, leads to
the local release of endothelium-dependent vasodilators (Busse
and Fleming, 2003). These vasodilators relax the larger arter-
ies and amplify the increase of flow, but there is limited
evidence supporting this possibility in the neocortical micro-
circulation. The hyperpolarization of vascular smooth muscle
travels rapidly through gap junctions for millimeters (de Wit,
2010) or within the endothelial tissue through the small (KCa
2.3; KCNN3)-and intermediate (KCa 3.1; KCNN4)-conductance
Ca2+-activated K+ channels (SKCa/IKCa) (Behringer and Segal,
2012).
WHAT IS THE SPECIFIC ROLE OF INTERNEURON-DERIVED
NO IN THE CONTROL OF CBF AMONG OTHER SOURCES?
There aremultiple sources of NO and all cell types of the brain can
produce NO.NO derives from three NOS isoforms as well as from
nitrite. In the central nervous system, the nNOS isoform is present
in interneurons, some pyramidal cells as well as nitrergic nerves
originating from pterygopalatine ganglia although their extra-
neuronal presence is still a matter of controversies. There are at
least three nNOS alternative-splice variants: nNOSα, nNOSβ, and
nNOSγ (Putzke et al., 2000; Saur et al., 2000). The mitNOS corre-
sponds to the nNOSα variant and could be inhibited by 7-NI. In
addition, only the nNOSα variant is knocked out in the nNOS
null mice (Putzke et al., 2000), which means that these mice
lack both neuronal and mitochondrial NOS. Neuronal NOSα
null mice are resistant to NMDA-induced neurotoxicity (Dawson
et al., 1996; Ayata et al., 1997). In a culture of rat hippocampal
neurons, it has been demonstrated that nNOS is totally localized
into mitochondria and activated by NMDA (Marks et al., 2005).
Therefore, it is very difficult to conclude the source of NO using
nNOS transgenic mice or 7-NI. Since NOS interneurons are very
specifically localized and serve as a relay to pyramidal neurons,
we could hypothesize that their primary function is the control of
NVC and local resting CBF rather than global CBF changes such
as in autoregulation or responses to (Ulker et al., 2009) systemic
changes in paCO2 or paO2. However, the subcellular localiza-
tion of NOS in interneurons remains controversial (Mizukawa
et al., 1988; Wolf et al., 1992; Aoki et al., 1993; Wiencken and
Casagrande, 2000).
Although, we already mentioned studies about the role of NOS
isoforms in resting CBF, autoregulation as well as responses to
paCO2 or paO2 variations, it is interesting to stress out the pos-
sible involvement of NO from blood cells in these mechanisms.
Although blood cells can produce a considerable amount of NO,
this aspect is rarely considered in neurovascular studies. Shear
stress, defined as the tangential forces acting on the luminal sur-
face of the vessel as a result of flow, could activate eNOS in
the endothelium as well as red blood cells NOS which is very
similar to eNOS (Ulker et al., 2009). In this regard, both endothe-
lial and red blood cells would play a role in CBF autoregula-
tion. Interestingly, red blood cells also contain functional NMDA
receptors, which upon activation increase NOS-dependent NO
production (Makhro et al., 2010). This may explain why resting
CBF is decreased in the presence of the NMDA inhibitor MK-801
although the effect of 7-NI on red blood cell NOS remain to be
assessed.
Another important source of NO in the brain is nitrite.
However, nitrite was recently found to have a direct effect on rest-
ing CBF in a rat model (Rifkind et al., 2007) and on the CBF in
response to hypercapnia and hypoxia in human (Peebles et al.,
2008). Nitrite concentrations in different mammalian tissues are
in general in micromolar range of 0.5–20μM (Samouilov et al.,
2007; Feelisch et al., 2008). Nitrite can be converted into NO
through the nitrite reductase activity of deoxyhemoglobin (Cosby
et al., 2003), xanthine oxidase (Li et al., 2008), aldehyde oxidase
(Li et al., 2009), carbonic anhydrase (Aamand et al., 2009), and all
isoforms of NOS (Mikula et al., 2009).
Overall, anatomical and physiological studies support a role of
NOS interneurons in NVC while other NOS containing cells or
nitrite seem to be rather responsible for the control of autoregu-
lation or the responses to hypercapnia and hypoxia. Nevertheless,
the development of specific NOS inhibitors is necessary to bring
appropriate answers to questions related to the origin of NO in
CBF regulation.
NO AND FUNCTIONAL BRAING IMAGING
Functional magnetic resonance imaging (fMRI) is often used
as a marker of changes in neuronal spiking activity. In real-
ity, fMRI detects CBF through the arterial spin label method
or blood oxygenation levels (BOLD) which reflects the shift
of the ratio between the local concentration of oxygenated
and deoxygenated hemoglobin due to increased oxygen extrac-
tion and increased oxygen supply. Unfortunately, the relation-
ship between hemodynamic changes and the actual underlying
response is still poorly understood. Anatomical and physiologi-
cal data about NOS interneurons strongly suggest a non-linear
relationship between neuronal activity and fMRI signals. In fact,
NOS interneurons account for 0.3% of all cortical neurons but
for about 50% of the vascular response to neuronal stimulation.
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In addition, the inhibition of nNOS with 7-NI clearly reduces
the BOLD response upon electrical forepaw stimulation while
the somatosensory-evoked potentials are still clearly detectable
and only slightly reduced in amplitude (Burke and Buhrle, 2006).
Overall, these studies strongly support the concept of a non-
linear relationship between the BOLD-fMRI signal and neuronal
stimulation (Membre et al., 1997; Yang et al., 2000).
However, interneurons may act as “local integrators” of cor-
tical activity and therefore have important implications for the
resulting neuronal activity and functional brain imaging (Buzsaki
et al., 2007). The resulting neuronal activity correlates with
increases in local field potentials rather than spikes. For exam-
ple, if the balance between excitation and inhibition does not
lead to the firing of action potentials, as demonstrated in the
visual cortex, the CBF response correlates with local field poten-
tials but not with spikes. Thus, local field potentials reflect
synchronized or correlated neuronal activity and are associated
with incoming input and local processing (Logothetis et al.,
2001). So, the CBF increase best reflects signal processing by
interneurons and electrophysiological events that do not result
in spikes. Nonetheless, the majority of studies suggest that the
relationship between CBF or BOLD signal and local field poten-
tials is non-linear. Consequently, fMRI signals should be carefully
interpreted as a non-linear result of local field potential and the
significance of NOS interneurons in this signal remain to be
elucidated.
CONCLUSION
NOS interneurons are strategically positioned close to blood ves-
sels and seem to be involved in the control of CBF. In NVC, the
mechanisms by which NO intervenes are particularly complex.
Actual data suggest that NO from interneurons play a cGMP-
dependent mediator role in the initiation of the vascular response
to neuronal activation followed by a cGMP-independentmodula-
tory role of astrocytic signals, which could lead to a vasodilation at
moderate concentrations or a vasoconstriction at higher concen-
trations. NO from different sources also seems to coordinate the
signal propagation of vasodilation upstream as well as the length
of the response. The involvement of inhibitory NOS interneurons
in NVC implies that the relationship between neuronal activity
and CBF is non-linear. Therefore, a better understanding of the
role of NOS interneurons in the control of CBF will allow a bet-
ter modelization and interpretation of BOLD signal used in fMRI
studies.
FUTURE DIRECTIONS
Since the discovery that NO is a powerful vasodilator, we have
made many observations to support its pivotal role in the cere-
brovascular regulation. However, a complete understanding of
the origin of NO and the pathways by which it controls the
vascular tone is still missing. Additional studies will have to
be conducted to further determine how NO intervene in NVC,
how it is released upon activation and how it interact with
astrocytes. As pharmacological blockers show evident limitations
when it comes to cell-type specificity, new techniques to unveil
the direct involvement of NOS expressing interneurons in NVC
have yet to be developed. A few transgenic mice models like
the Arx (Colombo et al., 2007; Price et al., 2009) and the Tsc1
(Fu et al., 2011) mutant mice, present a diminished expression of
NPY interneurons in the cortex. It would be interesting to ver-
ify whether CBF regulation is impaired in these models and what
proportion of the remaining interneurons expresses nNOS. As
these transgenic mice model might present compensatory mech-
anism and reorganization of the neural circuitry, more targeted
approaches might be needed. Recently, a new method for specific
elimination of nNOS expressing interneurons in acute slices using
induced photo-toxicity has been elaborated (Shlosberg et al.,
2012). However, the most promising tool will be conditional
transgenic optogenetic silencing using Cre driver lines allowing
the investigations of neural circuit function with unprecedented
reliability and accuracy.
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